Skip to main content

agilon health inc

For the period ended May 28, 2025. Filed Apr 17, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 28, 2025 · Filed Apr 17, 2025

AGL$113.39-0.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Proxy Statement Summary

This summary highlights information contained elsewhere in this proxy statement. This summary does not contain all of the information that you should consider, and you should read the entire proxy statement carefully before voting. Page references are supplied to help you find further information in this proxy statement.

MEETING INFORMATION

Date Wednesday, May 28, 2025Time 12:00 p.m., Eastern TimeLocation Via live webcast at www.virtualshare holdermeeting.com/ AGL2025Who Can Vote Stockholders of record as of April 4, 2025

WAYS TO VOTE

Stockholders of record holding shares of common stock, par value $0.01 per share (the “common stock”) as of the close of business on April 4, 2025 (the “Record Date”) are entitled to vote at the Annual Meeting. Beneficial owners whose Shares are held at a brokerage firm or by a bank or other nominee should follow the voting instructions that they received from the nominee.

InternetPlease log on to www.proxyvote.com and submit a proxy to vote your common stock by 11:59 p.m., Eastern Time, on May 27, 2025.Telephone Please call the number on your proxy card until 11:59 p.m., Eastern Time, on May 27, 2025.Mail If you received printed copies of the proxy materials, you may vote by mail. Please return your proxy card to the address listed so that it is received prior to the Annual Meeting.Virtually You may attend the virtual Annual Meeting and cast your vote. Stockholders present virtually during the Annual Meeting will be considered present in person.

VOTING RECOMMENDATIONS

Proposals · Board Vote Recommendation · For Further Details
1Election of two Class I directors for a three-year term ending at the 2028 Annual Meeting of StockholdersFOR each nomineePage 61
2Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025FORPage 62
3Advisory vote to approve the compensation paid to the Company’s named executive officersFORPage 64
agilon health 2025 Proxy Statement |1

PROXY STATEMENT SUMMARY

BOARD NOMINEES

The following table sets forth the names and certain other information for each of the nominees for election as a Class I director as of March 31, 2025.

Nominees · Current Occupation · Age · DirectorSince · Independent
Silvana BattagliaExecutive Vice President and Chief Human Resources Officer for Cencora572023
Sharad Mansukani, M.D.Chairman of Convey Health Solutions Senior, director of Monogram Health, Inc., trustee of the Children’s Hospital of Philadelphia, advisor to TPG, and member of The Wharton School Healthcare Policy Board552017

OUR VISION

To transform the future of health care in 100+ communities across the country by facilitating exceptional

patient-physician relationships.

OUR MISSION

To be the trusted long-term partner of community-based physicians, enabling them to reimagine the patient experience for older adults and lead the transformation of care delivery in their communities.

OUR PURPOSE

Empowering physicians to transform healthcare in our communities.

agilon health 2025 Proxy Statement |2

PROXY STATEMENT SUMMARY

OUR VALUES

Partnership & CollaborationQuality & ServiceAccountability & IntegrityContinuous Improvement
ExcellenceExpertiseInnovation

EXECUTIVE COMPENSATION PROGRAM DESIGN AND GOVERNANCE PRACTICES

Our executive compensation program is designed to provide strong alignment between executive pay, stockholder interests, and company performance, and incorporates best practices such as the following:

WHAT WE DOReward our executives commensurate with their performance, experience and capabilities
Reward achievement of short-term business objectives and results
Align executive and stockholder interests
Create “ownership culture” with equity awards
Provide employment retention incentives
Provide competitive employee benefits
Reward achievement of goals related to our team and culture engagement plan, leadership development and our inclusion and belonging priorities
Emphasize long-term growth through maximizing focus on increasing stockholder value
WHAT WE DON’T DO​Do not hedge or monetize transactions with respect to the Company’s securities
​Do not pledge the Company’s securities as collateral for a loan
​Do not use compensation practices that encourage unnecessary and excessive risk taking
Do not provide dividends or dividend equivalents on unearned PSUs unless and until the underlying PSU vests (and if such PSUs are forfeited, no dividend equivalents are paid out)
Do not grant stock options or stock appreciation rights with an exercise price less than the fair market value on the grant date
agilon health 2025 Proxy Statement |3

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be Held on May 28, 2025.

The proxy statement and annual report to stockholders are available atwww.proxyvote.com or www.investors.agilonhealth.com

In accordance with rules and regulations adopted by the SEC, we are pleased to provide access to our proxy materials over the Internet to all of our stockholders rather than in paper form. Accordingly, the Notice of Internet Availability has been mailed to our stockholders on or about April 17, 2025. Stockholders will have the ability to access the proxy materials on the websites listed above, or to request a printed set of the proxy materials be sent to them by following the instructions in the Notice of Internet Availability. By furnishing a Notice of Internet Availability and access to our proxy materials by the Internet, we are lowering the costs and reducing the environmental impact of our annual meeting.

The Notice of Internet Availability also provides instructions on how you may request that we send future proxy materials to you by electronic mail or in printed form by mail. If you choose to receive future proxy materials by electronic mail, you will receive an electronic mail next year with instructions containing a link to those materials and a link to the proxy voting site. Your election to receive proxy materials by electronic mail or in printed form by mail will remain in effect until you terminate it. We encourage you to choose to receive future proxy materials by electronic mail, which will allow us to provide you with the information you need expeditiously, will save us the cost of printing and mailing documents to you, and will conserve natural resources.

agilon health 2025 Proxy Statement |4
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.